Cognition Therapeutics Inc - Company Review
Cognition Therapeutics Inc - Company ReviewSummary
Cognition Therapeutics Inc (CogRx) is a drug discovery and development company that discovers and develops small molecule therapeutics. The company uses its proprietary biology and chemistry platforms for the development of novel drug targets and disease modifying therapies for the treatment of central nervous system disorders. Its products target the toxic proteins that cause the cognitive decline associated with Alzheimer's disease and can efficiently displace toxic beta amyloid oligomers bound to receptor proteins on brain cells. The company uses screening strategies to identify small molecules capable of blocking the central toxicity of soluble oligomeric proteins. It also conducts clinical trials. CogRx is headquartered in Pittsburgh, Pennsylvania, the US.
This comprehensive company report of Cognition Therapeutics Inc provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.